Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_assertion type Assertion NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_head.
- NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_assertion description "[Activated PI3K-AKT pathway may contribute to decrease sensitivity to inhibitors of key pathogenetic effectors (mutated BRAF, active NRAS or MEK) in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_provenance.
- NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_assertion evidence source_evidence_literature NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_provenance.
- NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_assertion SIO_000772 25627962 NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_provenance.
- NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_assertion wasDerivedFrom befree-2016 NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_provenance.
- NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_assertion wasGeneratedBy ECO_0000203 NP1258981.RA5JIVpYRx8qYWLf0T2zYopYSFN_68FZ2t2SR7xhi2fT4130_provenance.